{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:04:14Z","timestamp":1788469454994,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-9\/2021-14\/200122"],"award-info":[{"award-number":["451-03-9\/2021-14\/200122"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-9\/2021-14\/200378"],"award-info":[{"award-number":["451-03-9\/2021-14\/200378"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.cbi.2021.109647","type":"journal-article","created":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T10:22:19Z","timestamp":1631355739000},"page":"109647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Antitumor activity, DNA and BSA interactions of novel copper(II) complexes with 3,4-dihydro-2(1H)-quinoxalinones"],"prefix":"10.1016","volume":"348","author":[{"given":"Jelena","family":"Petronijevi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Joksimovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilija","family":"Milovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija \u0110or\u0111i\u0107","family":"Crnogorac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Petrovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Stanojkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du\u0161an","family":"Milivojevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Jankovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2021.109647_bib1","series-title":"Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug","author":"Lippert","year":"1999"},{"key":"10.1016\/j.cbi.2021.109647_bib2","first-page":"38","article-title":"Naziv rada","volume":"5","author":"Rafique","year":"2010","journal-title":"Biotechnol. Mol. Biol. Rev."},{"key":"10.1016\/j.cbi.2021.109647_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/A:1006490226104","article-title":"A randomized trial comparing the nephrotoxicity of cisplatin\/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors","volume":"18","author":"Hartmann","year":"2000","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.cbi.2021.109647_bib4","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"9","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2021.109647_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/1535-7163.MCT-08-0840","article-title":"Platinum neurotoxicity pharmacogenetics","volume":"8","author":"McWhinney","year":"2009","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.cbi.2021.109647_bib6","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.cbi.2021.109647_bib7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2147\/DDDT.S119488","article-title":"Metal complexes in cancer therapy \u2013 an update from drug design perspective","volume":"11","author":"Ndagi","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.cbi.2021.109647_bib8","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1039\/C3DT52524D","article-title":"A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds","volume":"43","author":"Bertrand","year":"2014","journal-title":"Dalton Trans."},{"key":"10.1016\/j.cbi.2021.109647_bib9","series-title":"Biology of Copper Complexes","first-page":"361","author":"Sorenson","year":"1987"},{"key":"10.1016\/j.cbi.2021.109647_bib10","first-page":"1","article-title":"Metal based drugs and chelating agents as therapeutic agents and their antimicrobial activity","volume":"64","author":"Din","year":"2019","journal-title":"Rev. Roum. Chem."},{"key":"10.1016\/j.cbi.2021.109647_bib11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ejmech.2014.06.058","article-title":"Quinoxaline, its derivatives and applications: a State of the Art review","volume":"97","author":"Pereira","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109647_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jccs.200700066","article-title":"Synthesis and antimicrobial activity of novel quinoxaline derivatives","volume":"54","author":"Badran","year":"2007","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.cbi.2021.109647_bib13","first-page":"2337","article-title":"Anti-inflammatory activity of novel substituted quinoxaline heterocycles","volume":"2","author":"Noorulla","year":"2011","journal-title":"Inter. J. Pharm. Sci. Res"},{"key":"10.1016\/j.cbi.2021.109647_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ardp.200700024","article-title":"Synthesis and Antidiabetic Activity of 3,6,7\u2010Trisubstituted\u20102\u2010(1H\u2010imidazole\u20102\u2010ylsulfanyl) quinoxalines and Quinoxalin\u20102\u2010yl isothioureas","volume":"340","author":"Bahekar","year":"2007","journal-title":"Arch. Pharm. Chem. Life Sci"},{"key":"10.1016\/j.cbi.2021.109647_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/088922200308936","article-title":"Long-term exposure of HIV type 1-infected cell cultures to combinations of the novel quinoxaline GW420867X with lamivudine, abacavir, and a variety of nonnucleoside reverse transcriptase inhibitors","volume":"16","author":"Balzarini","year":"2000","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.cbi.2021.109647_bib16","first-page":"439","volume":"8","author":"Naylor","year":"1993","journal-title":"Anticancer Drug Des"},{"key":"10.1016\/j.cbi.2021.109647_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejmech.2015.11.031","article-title":"Discovery of indeno[1,2-b]quinoxaline derivatives as potential anticancer agents","volume":"108","author":"Tseng","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109647_bib18","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0968-0896(03)00119-6","article-title":"Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-Oxide derivatives","volume":"11","author":"Zarranz","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109647_bib19","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1016\/j.poly.2007.04.014","article-title":"Structural, spectroscopic and redox properties of transition metal complexes of dipyrido[3,2-f:2\u2032,3\u2032-h]-quinoxaline (dpq)","volume":"26","author":"Ghosh","year":"2007","journal-title":"Polyhedron"},{"key":"10.1016\/j.cbi.2021.109647_bib20","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.poly.2008.04.017","article-title":"Influence of counter anions on structural, spectroscopic and electrochemical behaviours of copper(II) complexes of dipyrido[3,2-f: 2\u2032,3\u2032-h]-quinoxaline (dpq)","volume":"27","author":"Biswas","year":"2008","journal-title":"Polyhedron"},{"key":"10.1016\/j.cbi.2021.109647_bib21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11243-007-0215-5","article-title":"Synthesis and characterization of novel (E,E)-dioxime and its mono- and polynuclear metal complexes containing azacrown moieties","volume":"32","author":"Biyiklio\u01e7lu","year":"2007","journal-title":"Trans. Met. Chem."},{"key":"10.1016\/j.cbi.2021.109647_bib22","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1039\/b715077f","article-title":"Non-covalent DNA binding and cytotoxicity of certain mixed-ligand ruthenium(II) complexes of 2,2\u2032-dipyridylamine and diimines","author":"Rajendiran","year":"2008","journal-title":"Dalton Trans."},{"key":"10.1016\/j.cbi.2021.109647_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.saa.2009.05.007","article-title":"Synthesis, characterization and antimicrobial activity of 3d transition metal complexes of a biambidentate ligand containing quinoxaline moiety","volume":"74","author":"Lakshmi","year":"2009","journal-title":"Spectrochim. Acta"},{"key":"10.1016\/j.cbi.2021.109647_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jinorgbio.2007.07.002","article-title":"Synthesis, characterization, DFT studies and DNA binding of mixed platinum (II) complexes containing quinoxaline and 1,2-dithiolate ligands","volume":"102","author":"Mitsopoulou","year":"2008","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.cbi.2021.109647_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1039\/C6GC02893D","article-title":"An enolate ion as a synthon in biocatalytic synthesis of 3,4-dihydro-2(1H)-quinoxalinones and 3,4-dihydro-1,4-benzoxazin-2-ones: lemon juice as an alternative to hazardous solvents and catalysts","volume":"19","author":"Petronijevi\u0107","year":"2017","journal-title":"Green Chem."},{"key":"10.1016\/j.cbi.2021.109647_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700308","article-title":"Biological evaluation of selected 3,4\u2010dihydro\u20102(1H)\u2010quinoxalinones and 3,4\u2010dihydro\u20101,4\u2010benzoxazin\u20102\u2010ones: molecular docking study","volume":"351","author":"Petronijevi\u0107","year":"2018","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.cbi.2021.109647_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12039-019-1681-y","article-title":"Experimental and computational analysis (DFT method) of some quinoxalinones and benzoxazinones: spectroscopic investigation (FT-IR, FT-Raman, UV-Vis, NMR)","volume":"131","author":"Petronijevi\u0107","year":"2019","journal-title":"J. Chem. Sci."},{"key":"10.1016\/j.cbi.2021.109647_bib28","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S1452-3981(23)15101-7","article-title":"Investigation of the electrochemical interaction behavior of DNA with 5-fluorouracil derivatives","volume":"6","author":"Zhang","year":"2011","journal-title":"Int. J. Electrochem. Sci."},{"key":"10.1016\/j.cbi.2021.109647_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cbi.2021.109647_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0022-1759(91)90327-C","article-title":"Rapid colorimetric assay for the quantification of leukemia inhibitory factor (LIF) and interleukin-6 (IL-6)","volume":"145","author":"Ohno","year":"1991","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cbi.2021.109647_bib31","first-page":"109","article-title":"The FRAME cytotoxicity test","volume":"43","author":"Clothier","year":"1995","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cbi.2021.109647_bib32","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1021\/ed083p1229","article-title":"The determination of the geometry of Cu(II) complexes: an EPR spectroscopy experiment","volume":"83","author":"Garribba","year":"2006","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.cbi.2021.109647_bib33","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3390\/ijms17101712","article-title":"MicroRNA in control of gene expression: an overview of nuclear functions","volume":"17","author":"Catalanotto","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2021.109647_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"microRNAs as oncogenes and tumor suppressors","volume":"302","author":"Zhang","year":"2007","journal-title":"Dev. Biol."},{"key":"10.1016\/j.cbi.2021.109647_bib35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1186\/s12885-017-3642-5","article-title":"MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer","volume":"17","author":"Park","year":"2017","journal-title":"BMC Canc."},{"key":"10.1016\/j.cbi.2021.109647_bib36","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bbagrm.2008.03.001","article-title":"MicroRNA-206: the skeletal muscle-specific myomiR","volume":"1779","author":"McCarthy","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2021.109647_bib37","doi-asserted-by":"crossref","first-page":"31921","DOI":"10.1074\/jbc.M109.046862","article-title":"MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation","volume":"284","author":"Song","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2021.109647_bib38","first-page":"63","article-title":"MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer","volume":"17","author":"Chen","year":"2017","journal-title":"Canc. Cell Int."},{"key":"10.1016\/j.cbi.2021.109647_bib39","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1038\/onc.2011.561","article-title":"MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways","volume":"31","author":"Qin","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2021.109647_bib40","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1021\/bi00745a020","article-title":"Quenching of fluorescence by oxygen. A probe for structural fluctuations in macromolecules","volume":"12","author":"Lakowicz","year":"1973","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2021.109647_bib41","first-page":"39","article-title":"Fluxes and accumulation of tetracyclines by human blood cells, Ress","volume":"72","author":"Gabler","year":"1991","journal-title":"Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109647_bib42","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1021\/jm010960b","article-title":"Cheminformatic models to predict binding affinities to human serum albumin","volume":"44","author":"Colmenajero","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109647_bib43","first-page":"215","article-title":"Bovine serum albumin interactions with metal complexes","volume":"87","author":"Topala","year":"2014","journal-title":"Clujul Med."},{"key":"10.1016\/j.cbi.2021.109647_bib44","doi-asserted-by":"crossref","first-page":"15067","DOI":"10.1039\/C6DT02257J","article-title":"Synthesis, characterization, biological activity, DNA and BSA binding study: novel copper(II) complexes with 2-hydroxy-4-aryl-4-oxo-2-butenoate","volume":"45","author":"Joksimovi\u0107","year":"2016","journal-title":"Dalton Trans."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721002854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721002854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:43:42Z","timestamp":1778715822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279721002854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":44,"alternative-id":["S0009279721002854"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109647","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitumor activity, DNA and BSA interactions of novel copper(II) complexes with 3,4-dihydro-2(1H)-quinoxalinones","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109647"}}